Viewing Study NCT01466595


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-01-25 @ 5:20 PM
Study NCT ID: NCT01466595
Status: COMPLETED
Last Update Posted: 2018-09-10
First Post: 2011-10-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Rifaximin as a Modulator of Microbial Translocation and Immune Activation
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Organization: